Phi Pharma None
Phi Pharma is a biopharmaceutical company located in Switzerland that focuses on discovering and developing drug conjugates to improve the treatment of diseases with high-medical need. Their technology allows for the development of targeted peptide drug conjugates through specific cellular targeting and efficient intra-cellular delivery. The company's programs are primarily focused on oncology and infectious diseases.
Estimated Revenue:
$11.5 trillion